BCR and B-cell chronic lymphocytic leukemia: Next, we investigated whether AID mutagenic activity contributes to drug resistance by subjecting AID WT and AID KO clones to the selective pressure of BCR pathway inhibitors, aiming to model in vitro what is observed in patients with CLL.